EARLY, ROUTINE PARALYSIS FOR INTRACRANIAL-PRESSURE CONTROL IN SEVERE HEAD-INJURY - IS IT NECESSARY

被引:111
|
作者
HSIANG, JK
CHESNUT, RM
CRISP, CB
KLAUBER, MR
BLUNT, BA
MARSHALL, LF
机构
[1] UNIV CALIF SAN DIEGO,MED CTR,DIV NEUROL SURG,SAN DIEGO,CA 92103
[2] UNIV CALIF SAN FRANCISCO,DEPT RADIOL,SAN FRANCISCO,CA 94143
关键词
HEAD INJURY; INTRACRANIAL PRESSURE; INTRACRANIAL HYPERTENSION; CRITICAL CARE; INTENSIVE CARE UNIT; COMPLICATIONS; NEUROMUSCULAR BLOCKING AGENTS; PARALYSIS; PHARMACOLOGICAL; LENGTH OF STAY; PATIENT OUTCOME ASSESSMENT;
D O I
10.1097/00003246-199409000-00019
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To investigate the efficacy of early, routine use of neuromuscular blocking agents for intracranial pressure management in patients with severe head injury. Design: Retrospective review of data from the Traumatic Coma Data Bank. The Traumatic Coma Data Bank was a collaborative project of the National Institute of Neurological Disorders and Stroke that involved four Level I trauma centers. The Traumatic Coma Data Bank prospectively collected data on 1,030 severe head-injured patients (Glasgow Coma Score of less than or equal to 8) between 1984 and 1987. Setting: Four Level I trauma centers coordinated by the National Institute of Neurological Disorders and Stroke. Patients: A total of 514 Traumatic Coma Data Bank patients who met study inclusion criteria were divided into two groups: group 1 consisted of 239 patients who were pharmacologically paralyzed starting within the first intensive care unit (ICU) shift or less than or equal to 6 hrs into the second shift and lasting for at least 12 hrs. Group 2 contained the remaining 275, patients who did not fulfill these criteria. Measurements and Main Results: We analyzed the acute care course of these patients from the time of injury through admission, resuscitation, and ICU stay, as well as their rehabilitation follow-up results for less than or equal to 1 yr. These two groups did not differ significantly regarding admission intracranial computed tomography diagnosis, admission Glasgow motor score, percentage of monitored time that intracranial pressure was greater than or equal to 20 mm Hg, or frequency of initial intracranial pressure greater than or equal to 20 mm Hg. In group 2, more patients were aged >40 yrs (24% vs. 15% in group 1) or had admission hypotension (33% in group 2 vs. 25% in group 1). Multivariate regression analysis showed that ICU stay was significantly longer in group 1 (mean 7.76 days) than group 2 (mean 4.84 days; p < .001). The occurrence of pneumonia was significantly higher in group 1 (29% vs. 15%, p < .001). There was a tendency toward a higher occurrence of sepsis in group 1, but this difference did not reach statistical significance (11% vs. 7%, p = .08). The final Glasgow Outcome Scale scores for the two groups were not significantly different in those survivors with good and moderate outcomes. Although there were more deaths in group 2 (39% vs. 24%, p < .001), there were more vegetative or severely disabled survivors in group 1 (8% vs. 4% and 21% vs. 13%, respectively). Conclusions: Our findings suggest that early, routine, long-term use of neuromuscular blocking agents in patients with severe head injuries to manage intracranial pressure does not improve overall outcome and may actually be detrimental because of the prolongation of their ICU stay and the increased frequency of extracranial complications associated with pharmacologic paralysis. We suggest that routine early management of the head-injured patient in the ICU should be accomplished using sedation alone and that neuromuscular blockade should be generally reserved for patients with intracranial hypertension who require escalation of treatment intensity.
引用
收藏
页码:1471 / 1476
页数:6
相关论文
共 50 条
  • [21] HIGHLIGHTING INTRACRANIAL-PRESSURE MONITORING IN PATIENTS WITH SEVERE ACUTE BRAIN TRAUMA
    FALCAO, ALE
    DANTAS, VP
    SARDINHA, LAC
    QUAGLIATO, EMAB
    DRAGOSAVAC, D
    ARAUJO, S
    TERZI, RGG
    ARQUIVOS DE NEURO-PSIQUIATRIA, 1995, 53 (3A) : 390 - 394
  • [22] TEMPORAL PROFILE OF OUTCOMES IN SEVERE HEAD-INJURY
    CHOI, SC
    BARNES, TY
    BULLOCK, R
    GERMANSON, TA
    MARMAROU, A
    YOUNG, HF
    JOURNAL OF NEUROSURGERY, 1994, 81 (02) : 169 - 173
  • [23] URAPIDIL-INDUCED INCREASE OF THE INTRACRANIAL-PRESSURE IN HEAD-TRAUMA PATIENTS
    SINGBARTL, G
    METZGER, G
    INTENSIVE CARE MEDICINE, 1990, 16 (04) : 272 - 274
  • [24] A Trial of Intracranial-Pressure Monitoring in Traumatic Brain Injury
    Chesnut, Randall M.
    Temkin, Nancy
    Carney, Nancy
    Dikmen, Sureyya
    Rondina, Carlos
    Videtta, Walter
    Petroni, Gustavo
    Lujan, Silvia
    Pridgeon, Jim
    Barber, Jason
    Machamer, Joan
    Chaddock, Kelley
    Celix, Juanita M.
    Cherner, Marianna
    Hendrix, Terence
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (26) : 2471 - 2481
  • [25] FENTANYL AND SUFENTANIL INCREASE INTRACRANIAL-PRESSURE IN HEAD TRAUMA PATIENTS
    SPERRY, RJ
    BAILEY, PL
    REICHMAN, MV
    PETERSON, JC
    PETERSEN, PB
    PACE, NL
    ANESTHESIOLOGY, 1992, 77 (03) : 416 - 420
  • [26] Online correlation of spontaneous arterial and intracranial pressure fluctuations in patients with diffuse severe head injury
    Reinert, Michael
    Andres, Robert H.
    Fuhrer, Martin
    Mueller, Alexander
    Schaller, Benoit
    Widmer, HansRuedi
    NEUROLOGICAL RESEARCH, 2007, 29 (05) : 455 - 462
  • [27] Continuous cerebral compliance monitoring in severe head injury: Its relationship with intracranial pressure and cerebral perfusion pressure
    Portella, G
    Cormio, M
    Citerio, G
    INTRACRANIAL PRESSURE AND BRAIN BIOCHEMICAL MONITORING, 2002, 81 : 173 - 175
  • [28] THE EFFECT OF ELEVATED INTRACRANIAL-PRESSURE ON THE VIBRATIONAL RESPONSE OF THE OVINE HEAD
    STEVANOVIC, M
    WODICKA, GR
    BOURLAND, JD
    GRABER, GP
    FOSTER, KS
    LANTZ, GC
    TACKER, WA
    CYMERMAN, A
    ANNALS OF BIOMEDICAL ENGINEERING, 1995, 23 (06) : 720 - 727
  • [29] PHARMACOKINETICS AND EFFECTS ON INTRACRANIAL-PRESSURE OF SUFENTANIL IN HEAD TRAUMA PATIENTS
    SCHOLZ, J
    BAUSE, H
    SCHULZ, M
    KLOTZ, U
    KRISHNA, DR
    POHL, S
    ESCH, JSA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (04) : 369 - 372